Success Stories in Manufacturing

 

Improving Weighing Process and Time to Market

Reducing finished product inventories and inconclusive microbial ID results


 
 

  1. Improving Weighing Process and Time to Market

 

Problem Working with sensitive and expensive substances in the pharmaceutical industry has been the reason for safety and costs challenges as well as compliance issues with FDA and GMP requirements. Loss of milligrams of substance meant lost of thousands of dollars.
Solution Coalesce partnered pharmaceutical companies with a developer of a novel Automated Weighing and Dosing System to increase the efficiency in Testing, Quality, Formulation, and Manufacturing departments. After installation of the automated weighing system, companies could manage dispensing and dosing operations at the workstation and with the highest precision.
Result Double the speed of their weighing processes. Increase experimental series 50% and add quality gains. Overall, time to market was reduced to half the time.

 

  1. Reducing finished product inventories and inconclusive microbial ID results.

 

Problem Bacterial and fungal contamination poses serious challenges to pharmaceutical companies, especially to those that don’t have the means to indentify microbes quickly and effectively. Carrying finished product inventories for a long time due to slow testing significantly increases costs and reduce margins.
Solution Coalesce partnered pharmaceutical companies with a developer of newly validated Microbial Identification System aimed at helping reduce test time and minimize risks associated with production downtime. Pharmaceutical companies doing phenotypic testing usually experienced inconsistent or inconclusive results and slow identification time. Those relying on outsourced services experienced either long turnaround time or expensive expedite service fees. After installation of a newly validated Genotyping Microbial Identification system, companies were able to obtain faster, more accurate and more reproducible results than traditional phenotypic methods.
Result Three-year return on investment of ~160% and break-even after 11 months (validation period 4 of months and payback period after validation of 7 months). Reduced cost in finished product inventory. Decreased number of IDs sent out to a contract lab, many of which required expedite processing and fees.